- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Virtual Event – Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder
Nonadherence is a serious problem that can compromise treatment effectiveness in psychiatry. This presentation will review the multidimensional factors that contribute to adherence, discuss consequences of poor adherence, and bring to light implementation strategies to address adherence.
Featuring
-
Alyssa Peckham, PharmD, BCPP (OPDC)
Clinical & Scientific Liaison
-
Miranda Fisher, PhD
Medical Science Liaison
Speakers Alyssa Peckham, PharmD, BCPP and Miranda Fisher, PhD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.